Berkshire Hathaway Acquires Occidental's Chemical Division for $9.7 Billion
Berkshire Hathaway acquires Occidental Petroleum's chemical division, OxyChem, for $9.7 billion. Occidental plans to use $6.5 billion from the deal to reduce its debt.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedHave an account? Sign in
Overview
- Berkshire Hathaway, led by Warren Buffett, is acquiring Occidental Petroleum's chemical division, OxyChem, in a significant transaction.
- The acquisition price for OxyChem is $9.7 billion, representing a substantial investment by Berkshire Hathaway into Occidental's assets.
- Occidental Petroleum intends to allocate $6.5 billion of the proceeds from this deal specifically towards reducing its existing debt obligations.
- This acquisition is considered by some to be potentially Warren Buffett's last major deal, highlighting its importance in his investment legacy.
- OxyChem generated $213 million in pretax earnings for Occidental in the second quarter, while Buffett remains chairman, guiding Berkshire's cash deployment.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources frame this acquisition as a potential capstone to Warren Buffett's legendary deal-making career, emphasizing a "passing of the torch" narrative to Greg Abel. They use speculative language and structural choices to highlight Buffett's personal involvement and legacy, even when company materials do not, shaping the story around his potential final major acquisition.
Articles (3)
FAQ
The acquisition, valued at $9.7 billion, is Berkshire Hathaway's largest deal since 2022 and represents a strategic move to expand its chemical portfolio, strengthen market position amid petrochemical industry consolidation, and invest in sustainability initiatives like carbon reduction, aligning with energy transition trends.
Occidental plans to use $6.5 billion of the proceeds from selling OxyChem to significantly reduce its debt, aiming to bring total principal debt below $15 billion by 2025, thus improving its financial position and enabling focus on carbon capture and low-carbon technologies.
OxyChem generated nearly $5 billion in sales and $213 million pretax earnings in Q2, providing Berkshire with stable cash flows and enhancing portfolio resilience, while for Occidental, the deal aids debt reduction and strengthens balance sheet, supporting strategic goals in oil and gas business development.
OxyChem's sustainability initiatives include circular economy practices and carbon reduction efforts. Additionally, a subsidiary of Occidental will retain environmental liabilities, with Glenn Springs Holdings Inc. continuing remedial project management, ensuring ongoing environmental responsibility.
History
- This story does not have any previous versions.